AAFA holds many research projects to understand patient awareness, knowledge, preferences and behaviors related to allergy prevention, management and treatment. AAFA’s research offers different views on the impact of allergies in the U.S. Research offers a helpful look at the allergy community.
AAFA’s Allergy Capitals report is a yearly research project. It finds the most challenging places to live with allergies during the spring and fall. This report ranks cities based on their average pollen level and their average medicine use.
AAFA’s Anaphylaxis in America study looks at patient, public and doctor attitudes and behaviors about anaphylaxis. The study was based on public and patient surveys. This study includes an article, Anaphylaxis in America: The Prevalence and Characteristics of Anaphylaxis in the United States, and a Letter to the Editor, Anaphylaxis in America: A National Physician Survey. Both of these were printed in the Journal of Allergy and Clinical Immunology.
AAFA and its food allergy division, Kids With Food Allergies (KFA), conducted a three-part food allergy study to understand the burden of food allergy from three populations: parents of children with food allergies, teen/young adult patients with food allergies and adults with food allergies.
This report presented by AAFA and the National Wildlife Federation talks about the impact climate change will have on people with asthma and allergies. Climate change causes longer allergy seasons and increases air pollution. This can create problems for people with asthma and allergies. We must act now to reduce risks.
AAFA is a part of the committee formed by the Institute of Medicine. This group looks at food allergy issues. This committee will develop a way to treat key issues. These issues include how to increase public awareness, support research and find research gaps, and inform ways to prevent food allergy.
AAFA, with the help of Harris Poll, took a survey about how patients use and choose medicine. It also looked at their attitudes about getting safe and helpful treatments. This study showed that allergy sufferers rely on and want access to pseudoephedrine (PSE).
AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!
AAFA’s State Honor Roll is a yearly research project. It helps find states with the most complete and ideal statewide public policies supporting people with asthma and allergies in U.S. schools. The goal of this report is to find states that work toward better school-based policies and help advocates nationwide.